ABC News' Dr. Tara Narula breaks down a new study suggesting that a common HIV medication may significantly reduce the risk ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

The researchers note that patients taking other types of HIV medications did not show ... “We have also developed a new inflammasome-blocking drug called K9, which is a safer and more effective ...